{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:41:58Z","timestamp":1780422118352,"version":"3.54.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,1,23]],"date-time":"2007-01-23T00:00:00Z","timestamp":1169510400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm World Sci"],"published-print":{"date-parts":[[2007,5,23]]},"DOI":"10.1007\/s11096-006-9039-1","type":"journal-article","created":{"date-parts":[[2007,1,22]],"date-time":"2007-01-22T10:10:25Z","timestamp":1169460625000},"page":"164-166","source":"Crossref","is-referenced-by-count":9,"title":["Levetiracetam in three cases of progressive myoclonus epilepsy"],"prefix":"10.1007","volume":"29","author":[{"given":"Savvas","family":"Papacostas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Kkolou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Papathanasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,1,23]]},"reference":[{"key":"9039_CR1","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1212\/01.WNL.0000110193.78872.DD","volume":"62","author":"C Crest","year":"2004","unstructured":"Crest C, Dupond S, Leguern E et\u00a0al. Levetiracetam in progressive myoclonic epilepsy. Neurology 2004;62:640\u20133.","journal-title":"Neurology"},{"key":"9039_CR2","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1212\/01.WNL.0000058755.38892.80","volume":"60","author":"P Kinrions","year":"2003","unstructured":"Kinrions P, Ibrahim N, Murphy K et\u00a0al. Efficacy of levetiracetam in a patient with Undverricht-Lundborg progressive myoclonic epilepsy. Neurology 2003;60:1394\u20135.","journal-title":"Neurology"},{"key":"9039_CR3","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.0013-9580.2004.56902.x","volume":"45","author":"A Magaudda","year":"2004","unstructured":"Magaudda A, Gelisse P, Genton P. Antimyoclonic effect of levetiracetam in 13 patients with Unverricht\u2013Lundborg disease: clinical observations. Epilepsia 2004;45:678\u201381.","journal-title":"Epilepsia"},{"key":"9039_CR4","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1126\/science.271.5256.1731","volume":"271","author":"LA Pennacchio","year":"1996","unstructured":"Pennacchio LA, Lehesjoki A-E, Stone NE et\u00a0al. Mutations in the gene encoding cystatin B in progressive myoclonic epilepsy (EPM1). Science 1996;271:1731\u20134.","journal-title":"Science"},{"key":"9039_CR5","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/WNL.57.6.1144-b","volume":"57","author":"P Genton","year":"2001","unstructured":"Genton P, Gelisse P. Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam. Neurology 2001;57:1144\u20135.","journal-title":"Neurology"},{"key":"9039_CR6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(01)01884-5","volume":"306","author":"I Niespodziany","year":"2001","unstructured":"Niespodziany I, Klitgaard H, Margineanu D-G. Levetiracetam inhibits the high-voltage activated Ca2+ current in pyramidal neurons of rat hippocampal slices. Neurosci Lett 2001;306:5\u20138.","journal-title":"Neurosci Lett"},{"key":"9039_CR7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.bjp.0704766","volume":"136","author":"JM Rigo","year":"2002","unstructured":"Rigo JM, Hans G, Nguyen L et\u00a0al. The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated current. Br J Pharmacol 2002;136:659\u201372.","journal-title":"Br J Pharmacol"},{"issue":"26","key":"9039_CR8","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","volume":"101","author":"BA Lynch","year":"2004","unstructured":"Lynch BA, Lambeng L, Nocka K et\u00a0al. The synaptic vescicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 2004;101(26):9861\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9039_CR9","doi-asserted-by":"crossref","unstructured":"Ben-Menachem E, Falter U, for the European Levetiracetam Study Group. Efficacy and tolerability of levetiracetam 3000\u00a0mg\/day in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. Epilepsia 2000;41:1276\u201383.","DOI":"10.1111\/j.1528-1157.2000.tb04605.x"},{"key":"9039_CR10","doi-asserted-by":"crossref","unstructured":"Kasteleijn-Nolst Trenite DGA, Hirsch E. Levetiracetam: preliminary efficacy in generalized seizures. Epileptic Disord 2003;5 Suppl 1:S39\u2013S44.","DOI":"10.1684\/j.1950-6945.2003.tb00029.x"}],"container-title":["Pharmacy World & Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-006-9039-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-006-9039-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-006-9039-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T03:19:01Z","timestamp":1736738341000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-006-9039-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,23]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,5,23]]}},"alternative-id":["9039"],"URL":"https:\/\/doi.org\/10.1007\/s11096-006-9039-1","relation":{},"ISSN":["0928-1231","1573-739X"],"issn-type":[{"value":"0928-1231","type":"print"},{"value":"1573-739X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,23]]}}}